Skip to main content

1 Result(s)

within Chuhong Hu Remove this filter Life Sciences Remove this filter

and

  1. Article

    Open Access

    Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia

    FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is a common mutation type in acute myeloid leukemia (AML) and is usually associated with poor patient prognosis. With advancements in molecular...

    Chuhong Hu, Yvyin Zhang, Jie Yang, Yanli Xu… in Cell Communication and Signaling (2024)

    Download PDF (7076 KB) View Article